Alphatec Holdings, Inc. Stock

Equities

ATEC

US02081G2012

Medical Equipment, Supplies & Distribution

Market Closed - Nasdaq 04:00:00 2024-04-24 pm EDT 5-day change 1st Jan Change
12.74 USD -1.28% Intraday chart for Alphatec Holdings, Inc. +1.84% -15.68%
Sales 2024 * 596M Sales 2025 * 717M Capitalization 1.76B
Net income 2024 * -150M Net income 2025 * -106M EV / Sales 2024 * 3.68 x
Net Debt 2024 * 439M Net Debt 2025 * 445M EV / Sales 2025 * 3.07 x
P/E ratio 2024 *
-11.7 x
P/E ratio 2025 *
-16.7 x
Employees 839
Yield 2024 *
-
Yield 2025 *
-
Free-Float 62.91%
More Fundamentals * Assessed data
Dynamic Chart

Latest transcript on Alphatec Holdings, Inc.

1 day-1.28%
1 week+1.84%
Current month-7.61%
1 month-3.63%
3 months-19.87%
6 months-0.62%
Current year-15.68%
More quotes
1 week
12.27
Extreme 12.27
13.08
1 month
12.27
Extreme 12.27
14.54
Current year
12.27
Extreme 12.27
17.34
1 year
8.66
Extreme 8.66
19.14
3 years
5.73
Extreme 5.73
19.14
5 years
2.19
Extreme 2.19
19.36
10 years
1.18
Extreme 1.18
23.04
More quotes
Managers TitleAgeSince
Chief Executive Officer 58 17-10-01
Director of Finance/CFO 52 21-04-18
Chief Operating Officer 43 17-09-30
Members of the board TitleAgeSince
Director/Board Member 56 17-06-14
Director/Board Member 61 17-02-07
Director/Board Member 76 18-03-07
More insiders
Date Price Change Volume
24-04-24 12.74 -1.47% 1,273,099
24-04-23 12.93 +1.09% 1,347,768
24-04-22 12.79 +1.99% 1,659,689
24-04-19 12.54 +1.62% 1,331,385
24-04-18 12.34 -1.36% 2,314,874

Delayed Quote Nasdaq, April 24, 2024 at 04:00 pm EDT

More quotes
Alphatec Holdings, Inc., through its wholly owned subsidiaries, Alphatec Spine, Inc., EOS imaging S.A.S. and SafeOp Surgical, Inc., is a medical device company. The Company is focused on the design, development, and advancement of technology for surgical treatment of spine disorders. It has a range of product portfolios designed to address the spine's various pathologies. Its AIX product platform comprises of its EOS imaging system and VEA alignment mobile application, its SafeOp Neural InformatiX System and Valence. The EOS imaging system is designed to provide calibrated full-body imaging that enables a three-dimensional (3D) model of patients’ skeletal systems. It has developed a patient positioning systems that integrates with its other access systems, providing for a more rigid construct and enhanced reproducibility. It offers procedure-specific access systems, including its Sigma-ALIF Access System, which allows for custom anterior abdominal exposure.
Calendar
Related indices
More about the company
Trading Rating
Investor Rating
ESG Refinitiv
C
More Ratings
Sell
Consensus
Buy
Mean consensus
BUY
Number of Analysts
11
Last Close Price
12.74 USD
Average target price
23.41 USD
Spread / Average Target
+83.74%
Consensus